Procedural aspects of DCB PCI

Facilitators: A. Colombo, R. Kornowski

Speakers: C. Gao, A. Håkansson, V. A. Jimenez Diaz, D. Galante, J. Kolanthaivelu

Summary

Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization strategies for high bleeding risk patients. Additionally, examine data on lesion characteristics, diabetes, IVUS use, and functionally guided DCB versus stent PCI outcomes.

Presentations available when logged in:

Impact of pre-dilatation balloon on de novo lesions treated with DCB
Ticagrelor vs. clopidogrel after PCI with DEB
Streamlining coronary revascularisation in high bleeding risk patients: sirolimus-DCB and SAPT
Real-world outcomes of DCBs in coronary angioplasty: lesion characteristics, diabetes and IVUS
Outcomes in functionally guided DCB vs. stent PCI: a propensity-matched analysis

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Procedural aspects of DCB PCI

Log in or create account for free